バイオバンキング市場：製品・サービス（装置、消耗品、サービス、ソフトウェア）、サンプルタイプ（血液、組織、核酸、細胞株）、所有者、用途（再生医療、ライフサイエンス、臨床研究）、エンドユーザー別 - 2028年までの世界予測

Biobanking Market by Product & Service (Equipment, Consumable, Services, Software), Sample Type (Blood, Tissue, Nucleic Acids, Cell lines), Ownership, Application (Regenerative Medicine, Life Science, Clinical Research), End User - Global Forecast to 2028

世界のバイオバンキング市場は、2023年の29億米ドルから2028年には50億米ドルに達し、2023年から2028年の予測期間中に11.4%のCAGRで成長すると予測されています。この市場の成長は、臍帯血幹細胞保存の需要に大き... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2023年5月24日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	324	426	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

世界のバイオバンキング市場は、2023年の29億米ドルから2028年には50億米ドルに達し、2023年から2028年の予測期間中に11.4%のCAGRで成長すると予測されています。この市場の成長は、臍帯血幹細胞保存の需要に大きく左右されます。新生児から臍帯血幹細胞を保存する傾向が強まったことで、臍帯血幹細胞の保存を専門とする臍帯血バンクやバイオバンクの数が大幅に増加しました。これらのバイオバンクは、臍帯血サンプルを長期保存し、サービスを提供しており、再生医療を研究する研究者や臨床医にとって貴重なリソースとなっています。

"予測期間中の製品別シェアは、消耗品セグメントが2位"
2022年、世界のバイオバンキング市場において、消耗品セグメントは製品別で2番目に大きなシェアを占めています。バイオバンキングの消耗品には、主に試薬や培地、核酸抽出キット、表面消毒剤、採取キット、スワブ、容器、注射器などがあります。消耗品はバイオバンキングに欠かせない不可欠な要素です。細胞、組織、臓器のバイオバンキングの需要が高まるにつれ、バイオバンキング機器や消耗品への要求が著しく高まっています。さらに、研究や臨床応用のために保管されるサンプルの数が増加していることから、バイオバンキング業界では保管機器に対する需要が高まっています。これらの傾向は、貴重な生物学的試料の完全性とアクセス性を維持するために、信頼性が高く効果的な保管用消耗品の重要性を強調するものです。

"ヨーロッパバイオバンキング市場で2番目に大きな地域"
欧州は、バイオバンキング市場において北米に次いで2番目に大きな市場です。欧州のバイオバンキング市場は、その拡大を後押しする様々な要因によって、近年著しい成長を遂げています。その一つは、個別化医療やプレシジョンヘルスケアへの注目が高まり、高品質の生体サンプルや関連データへの需要が急増していることです。さらに、ゲノム研究の進展や次世代シーケンサー技術の登場により、膨大な生物試料の保管場所の必要性が高まり、欧州全域でバイオバンク活動の成長に拍車をかけています。欧州のバイオバンク市場のこのような上昇傾向は、生物医学研究を促進し、革新的な診断法、治療法、患者の転帰を改善する治療法の開発を可能にするという、バイオバンクの重要な役割を示しています。

本レポートのために実施した主要なインタビューは、以下のように分類されます：

- 回答者別回答者別：供給側80％、需要側20
- 役職別Cレベル-45％、Dレベル-30％、その他-25
- 地域別北米：20％、欧州：10％、アジア太平洋：55％、中南米：10％、中近東・アフリカ：5
レポート掲載企業一覧
- サーモフィッシャーサイエンティフィック株式会社（米国）
- 株式会社PHCホールディングス（日本）
- ベクトン・ディッキンソン・アンド・カンパニー（米国）
- QIAGEN N.V.(ドイツ)
- メルクKGaA（ドイツ）
- Avantor, Inc.（米国）
- Cryoport, Inc.(米国)
- Tecan Trading AG（スイス）
- アゼンタ・インク（米国）
- グレイナーホールディングAG（オーストリア）
- ハミルトン社(米国)
- マイクロニック社（オランダ）
- AMSBIO（イギリス）
- ベイ・バイオサイエンシズLLC（米国）
- バイオクライオ（ドイツ）
- SPT Labtech（イギリス）
- アスキオン社（ドイツ）
- Cell&Co BioServices（フランス）
- Ziath Ltd.(イギリス)
- CTIBiotech（フランス）
- キュアライン（米）
- フィラリスグループ（フランス）
- Sopachem（オランダ）
- プロテオジェネックス（米国）
- US Biolab Corporation, Inc.（米国）

調査範囲です：
本レポートは、バイオバンキング市場の詳細な情報を提供します。製品＆サービス、サンプルタイプ、ストレージタイプ、所有権、アプリケーション、エンドユーザー、地域などの異なるセグメントにおける市場規模および今後の成長可能性を推定することを目的としています。また、主要な市場プレイヤーの会社概要や最近の開発状況、主要な市場戦略とともに、詳細な競合分析も掲載しています。
レポートを購入する主な利点
本レポートは、市場全体とそのサブセグメントにおける収益数の最も近い近似値を提供することで、市場リーダーや新規参入者の助けとなります。また、利害関係者が競争環境をよりよく理解し、より多くの洞察を得ることで、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てることができるようになるでしょう。本レポートは、関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、機会、および課題に関する情報を提供することを可能にします。
以下のポイントに関する洞察を提供します：
- 市場の成長に影響を与える主要な推進要因（バイオバンクへの投資と資金の増加、遺伝子検査と精密医療への注力、新生児の臍帯血幹細胞保存の傾向の増加、再生医療に関連する研究への有利な資金調達シナリオ）、阻害要因（自動化機器の高コスト、生物試料管理に関する問題）、機会（新興国が有利な機会を提供）、課題（バイオバンクの高い運用コスト、サンプルの保管）についての分析。
- 製品およびサービスの開発/革新：新しく発売された製品・サービスに関する詳細なインサイト、バイオバンク市場の技術的評価
- 市場開発：有利な市場に関する包括的な情報 - 本レポートでは、さまざまな地域の市場を分析しています。
- 市場の多様化：新製品・サービス、未開拓の地域、最近の開発、バイオバンキング市場への投資に関する詳細な情報
- 競争力のある評価：Thermo Fisher Scientific, Inc.（米国）、PHC Holdings Corporation（日本）、Becton, Dickinson and Company（米国）、QIAGEN N.V.（ドイツ）、Merck KGaA（ドイツ）、Avantor, Inc.（米国）などの主要企業の市場シェア、成長戦略、製品およびサービス提供について詳細に評価。(米国）、Cryoport, Inc.（米国）、Tecan Trading AG（スイス）、Azenta, Inc.（米国）、Greiner Holding AG（オーストリア）、Hamilton Company（米国）、Micronic（オランダ）、AMSBIO（英国）、Bay Biosciences LLC（米国）、BioKryo（ドイツ）、SPT Labtech（英国）、ASKION GmbH（ドイツ）、Cell & Co BioServices（フランス）、Ziath Ltd.(英国）、CTIBiotech（フランス）、Cureline（米国）、Firalis Group（フランス）、Sopachem（オランダ）、ProteoGenex（米国）、US Biolab Corporation, Inc. 米国）などが市場に存在します。

ページTOPに戻る

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS AND EXCLUSIONS 30
1.3 MARKET SCOPE 31
1.3.1 MARKETS COVERED 31
1.3.2 YEARS CONSIDERED 31
1.4 CURRENCY CONSIDERED 32
1.5 RESEARCH LIMITATIONS 32
1.6 STAKEHOLDERS 32
1.7 SUMMARY OF CHANGES 33
1.7.1 IMPACT OF ECONOMIC RECESSION 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
FIGURE 1 RESEARCH DESIGN 35
2.1.1 SECONDARY DATA 36
2.1.2 PRIMARY DATA 36
2.1.2.1 Breakdown of primaries 37
2.2 MARKET ESTIMATION METHODOLOGY 38
FIGURE 2 BIOBANKING MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS 38
FIGURE 3 MARKET SIZE ESTIMATION - COMPANY REVENUE ANALYSIS (2022) 38
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 39
FIGURE 4 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 39
2.3 MARKET GROWTH RATE PROJECTIONS 41
FIGURE 5 BIOBANKING MARKET (SUPPLY-SIDE): CAGR PROJECTIONS 41
FIGURE 6 BIOBANKING MARKET: GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 42
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 43
FIGURE 7 DATA TRIANGULATION METHODOLOGY 43
2.5 STUDY ASSUMPTIONS 44
2.6 IMPACT OF RECESSION ON BIOBANKING MARKET 44
TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2024−2027 44
2.7 RISK ANALYSIS 45

3 EXECUTIVE SUMMARY 46
FIGURE 8 BIOBANKING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 46
FIGURE 9 BIOBANKING MARKET, BY STORAGE TYPE, 2023 VS. 2028 (USD MILLION) 47
FIGURE 10 BIOBANKING MARKET, BY SAMPLE TYPE, 2023 VS. 2028 (USD MILLION) 47
FIGURE 11 BIOBANKING MARKET, BY OWNERSHIP, 2023 VS. 2028 (USD MILLION) 48
FIGURE 12 BIOBANKING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 48
FIGURE 13 BIOBANKING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 49
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF BIOBANKING MARKET 50
4 PREMIUM INSIGHTS 51
4.1 BIOBANKING MARKET OVERVIEW 51
FIGURE 15 GROWING INVESTMENTS AND FUNDING FOR BIOBANKS TO DRIVE MARKET 51
4.2 NORTH AMERICA: BIOBANKING MARKET, BY STORAGE TYPE AND COUNTRY (2022) 52
FIGURE 16 MANUAL STORAGE ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN BIOBANKING MARKET IN 2022 52
4.3 BIOBANKING MARKET SHARE, BY APPLICATION, 2023 VS. 2028 52
FIGURE 17 REGENERATIVE MEDICINE SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2028 52
4.4 BIOBANKING MARKET SHARE, BY END USER (2023) 53
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 53
4.5 BIOBANKING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 53
FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 20 BIOBANKING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
TABLE 2 BIOBANKING MARKET: IMPACT ANALYSIS 55
5.2.1 DRIVERS 55
5.2.1.1 Growing investments and funding for biobanks 55
5.2.1.2 Focus on genetic testing and precision medicine 56
5.2.1.3 Increasing trend in preservation of cord blood stem cells from newborns 56
5.2.1.4 Favorable funding scenario for research related to regenerative medicine 57
5.2.2 RESTRAINTS 58
5.2.2.1 High cost of automated equipment 58
5.2.2.2 Issues related to biospecimen sample management 58
5.2.3 OPPORTUNITIES 59
5.2.3.1 Emerging economies to provide lucrative opportunities 59
5.2.4 CHALLENGES 59
5.2.4.1 High operational cost of biobanks 59
5.2.4.2 Storage of samples 59
5.3 RANGES/SCENARIOS 60
FIGURE 21 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 61
FIGURE 22 REVENUE SHIFT AND NEW REVENUE POCKETS FOR BIOBANKING PRODUCT PROVIDERS 61
5.5 PRICING ANALYSIS 61
5.5.1 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS 61
TABLE 3 PRICE OF BIOBANKING PRODUCTS, BY KEY PLAYER 61
5.5.2 AVERAGE SELLING PRICE TREND 61
5.6 VALUE CHAIN ANALYSIS 62
FIGURE 23 VALUE CHAIN ANALYSIS OF BIOBANKING MARKET 62
5.7 SUPPLY CHAIN ANALYSIS 63
FIGURE 24 BIOBANKING MARKET: SUPPLY CHAIN ANALYSIS 64
5.8 ECOSYSTEM ANALYSIS 64
FIGURE 25 ECOSYSTEM ANALYSIS: BIOBANKING MARKET 64
TABLE 4 SUPPLY CHAIN ECOSYSTEM 65
5.9 PATENT ANALYSIS 66
FIGURE 26 PATENT APPLICATIONS FOR BIOBANKING MARKET, JANUARY 2013–APRIL 2023 66
5.10 KEY CONFERENCES AND EVENTS IN 2023 67
TABLE 5 BIOBANKING MARKET: LIST OF CONFERENCES AND EVENTS 67
5.11 REGULATORY ANALYSIS 68
5.11.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS IN DIFFERENT REGIONS/COUNTRIES 68
5.12 PORTER’S FIVE FORCES ANALYSIS 69
TABLE 6 BIOBANKING MARKET: PORTER’S FIVE FORCES ANALYSIS 69
5.12.1 THREAT OF NEW ENTRANTS 69
5.12.2 THREAT OF SUBSTITUTES 69
5.12.3 BARGAINING POWER OF BUYERS 69
5.12.4 BARGAINING POWER OF SUPPLIERS 70
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 70
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 70
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 70
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOBANKING PRODUCTS 70
5.13.2 KEY BUYING CRITERIA FOR BIOBANKING PRODUCTS AMONG END USERS 71
FIGURE 28 KEY BUYING CRITERIA FOR END USERS 71

6 BIOBANKING MARKET, BY PRODUCT & SERVICE 72
6.1 INTRODUCTION 73
TABLE 7 BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 73
6.2 EQUIPMENT 73
TABLE 8 BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 74
TABLE 9 BIOBANKING EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 74
TABLE 10 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74
TABLE 11 EUROPE: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 12 ASIA PACIFIC: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 13 LATIN AMERICA: BIOBANKING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
6.2.1 STORAGE EQUIPMENT 76
6.2.1.1 Storage solutions for biobanking to ensure integrity and longevity of biological samples 76
TABLE 14 STORAGE EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 76
TABLE 15 NORTH AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 16 EUROPE: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 17 ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 18 LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
6.2.2 SAMPLE ANALYSIS EQUIPMENT 78
6.2.2.1 Ensures sample integrity, traceability, and preservation 78
TABLE 19 SAMPLE ANALYSIS EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 78
TABLE 20 NORTH AMERICA: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 21 EUROPE: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 22 ASIA PACIFIC: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 23 LATIN AMERICA: SAMPLE ANALYSIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 80
6.2.3 SAMPLE PROCESSING EQUIPMENT 80
6.2.3.1 Demand for reliable biobanking equipment to propel adoption 80
TABLE 24 SAMPLE PROCESSING EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 81
TABLE 25 NORTH AMERICA: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 26 EUROPE: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 27 ASIA PACIFIC: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 28 LATIN AMERICA: SAMPLE PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
6.2.4 SAMPLE TRANSPORT EQUIPMENT 83
6.2.4.1 Need for reliable transport equipment to maintain sample integrity and quality to drive market 83
TABLE 29 SAMPLE TRANSPORT EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 30 NORTH AMERICA: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 31 EUROPE: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 32 ASIA PACIFIC: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 33 LATIN AMERICA: SAMPLE TRANSPORT EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
6.3 CONSUMABLES 85
TABLE 34 BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 85
TABLE 35 BIOBANKING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 86
TABLE 36 NORTH AMERICA: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 37 EUROPE: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 38 ASIA PACIFIC: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 39 LATIN AMERICA: BIOBANKING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
6.3.1 STORAGE CONSUMABLES 87
6.3.1.1 Play crucial role in preserving integrity and viability of samples 87
TABLE 40 STORAGE CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 41 NORTH AMERICA: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 42 EUROPE: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 43 ASIA PACIFIC: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 44 LATIN AMERICA: STORAGE CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
6.3.2 ANALYSIS CONSUMABLES 90
6.3.2.1 Increasing demand for sample analysis to fuel adoption 90
TABLE 45 ANALYSIS CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 90
TABLE 46 NORTH AMERICA: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 47 EUROPE: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 48 ASIA PACIFIC: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 49 LATIN AMERICA: ANALYSIS CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
6.3.3 PROCESSING CONSUMABLES 92
6.3.3.1 Use of sample processing consumables for efficient biobanking to drive growth 92
TABLE 50 PROCESSING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 92
TABLE 51 NORTH AMERICA: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 52 EUROPE: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 53 ASIA PACIFIC: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 54 LATIN AMERICA: PROCESSING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
6.3.4 COLLECTION CONSUMABLES 94
6.3.4.1 Demand for efficient sample handling to drive adoption 94
TABLE 55 COLLECTION CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 56 NORTH AMERICA: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 57 EUROPE: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 58 ASIA PACIFIC: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 59 LATIN AMERICA: COLLECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
6.4 SERVICES 96
TABLE 60 BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 97
TABLE 61 BIOBANKING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 97
TABLE 62 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 63 EUROPE: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 64 ASIA PACIFIC: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 65 LATIN AMERICA: BIOBANKING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
6.4.1 STORAGE SERVICES 99
6.4.1.1 Increasing number of biological samples to fuel demand for storage services 99
TABLE 66 STORAGE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 67 NORTH AMERICA: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 68 EUROPE: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 69 ASIA PACIFIC: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 70 LATIN AMERICA: STORAGE SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 101
6.4.2 PROCESSING SERVICES 101
6.4.2.1 Critical for preparation of samples for storage and analysis 101
TABLE 71 PROCESSING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 102
TABLE 72 NORTH AMERICA: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 73 EUROPE: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 74 ASIA PACIFIC: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 75 LATIN AMERICA: PROCESSING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
6.4.3 TRANSPORT SERVICES 103
6.4.3.1 Help in facilitating biobanking operations 103
TABLE 76 TRANSPORT SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 104
TABLE 77 NORTH AMERICA: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 78 EUROPE: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 79 ASIA PACIFIC: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 80 LATIN AMERICA: TRANSPORT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
6.4.4 SUPPLY SERVICES 106
6.4.4.1 Supply services for biobanking to enable research and discovery 106
TABLE 81 SUPPLY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 106
TABLE 82 NORTH AMERICA: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 83 EUROPE: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 84 ASIA PACIFIC: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 85 LATIN AMERICA: SUPPLY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
6.5 SOFTWARE 108
6.5.1 RISING ADOPTION OF BIOBANKING SOFTWARE TO MANAGE BIOLOGICAL SAMPLES TO DRIVE GROWTH 108
TABLE 86 BIOBANKING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION) 109
TABLE 87 NORTH AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 88 EUROPE: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 89 ASIA PACIFIC: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 90 LATIN AMERICA: BIOBANKING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
7 BIOBANKING MARKET, BY STORAGE TYPE 111
7.1 INTRODUCTION 112
TABLE 91 BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 112
7.2 MANUAL STORAGE 112
7.2.1 POPULARITY OF MANUAL STORAGE OVER AUTOMATED STORAGE TO SUPPORT MARKET GROWTH 112
TABLE 92 BIOBANKING MARKET FOR MANUAL STORAGE, BY REGION, 2021–2028 (USD MILLION) 113
TABLE 93 NORTH AMERICA: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 94 EUROPE: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 95 ASIA PACIFIC: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 96 LATIN AMERICA: BIOBANKING MARKET FOR MANUAL STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 114
7.3 AUTOMATED STORAGE 115
7.3.1 EFFICIENT TRACKING OF SAMPLES AND REDUCTION OF MANUAL ERRORS TO DRIVE MARKET 115
TABLE 97 BIOBANKING MARKET FOR AUTOMATED STORAGE, BY REGION, 2021–2028 (USD MILLION) 115
TABLE 98 NORTH AMERICA: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 99 EUROPE: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 100 ASIA PACIFIC: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 101 LATIN AMERICA: BIOBANKING MARKET FOR AUTOMATED STORAGE, BY COUNTRY, 2021–2028 (USD MILLION) 117
8 BIOBANKING MARKET, BY SAMPLE TYPE 118
8.1 INTRODUCTION 119
TABLE 102 BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 119
8.2 BLOOD PRODUCTS 119
8.2.1 USE IN WIDE RANGE OF APPLICATIONS TO PROPEL MARKET 119
TABLE 103 BIOBANKING MARKET FOR BLOOD PRODUCTS, BY REGION, 2021–2028 (USD MILLION) 120
TABLE 104 NORTH AMERICA: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 105 EUROPE: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 106 ASIA PACIFIC: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 107 LATIN AMERICA: BIOBANKING MARKET FOR BLOOD PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 122
8.3 HUMAN TISSUES 122
8.3.1 PIVOTAL ROLE IN FACILITATING SCIENTIFIC DISCOVERIES AND IMPROVING PATIENT CARE TO DRIVE MARKET 122
TABLE 108 BIOBANKING MARKET FOR HUMAN TISSUES, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 109 NORTH AMERICA: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 110 EUROPE: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 111 ASIA PACIFIC: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 112 LATIN AMERICA: BIOBANKING MARKET FOR HUMAN TISSUES, BY COUNTRY, 2021–2028 (USD MILLION) 124
8.4 CELL LINES 125
8.4.1 SERVE AS VALUABLE RESOURCES IN BIOBANKING 125
TABLE 113 BIOBANKING MARKET FOR CELL LINES, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 114 NORTH AMERICA: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 115 EUROPE: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 116 ASIA PACIFIC: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 117 LATIN AMERICA: BIOBANKING MARKET FOR CELL LINES, BY COUNTRY, 2021–2028 (USD MILLION) 127
8.5 NUCLEIC ACIDS 127
8.5.1 GROWING DEMAND FOR STORAGE AND ANALYSIS OF NUCLEIC ACIDS TO DRIVE MARKET 127
TABLE 118 BIOBANKING MARKET FOR NUCLEIC ACIDS, BY REGION, 2021–2028 (USD MILLION) 128
TABLE 119 NORTH AMERICA: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 120 EUROPE: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 121 ASIA PACIFIC: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 122 LATIN AMERICA: BIOBANKING MARKET FOR NUCLEIC ACIDS, BY COUNTRY, 2021–2028 (USD MILLION) 130
8.6 BIOLOGICAL FLUIDS 130
8.6.1 SERVE AS VALUABLE RESOURCES FOR RESEARCHERS AND CLINICIANS IN STUDYING DISEASES 130
TABLE 123 BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 124 NORTH AMERICA: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 125 EUROPE: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 126 ASIA PACIFIC: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 127 LATIN AMERICA: BIOBANKING MARKET FOR BIOLOGICAL FLUIDS, BY COUNTRY, 2021–2028 (USD MILLION) 133
8.7 HUMAN WASTE PRODUCTS 133
8.7.1 USE OF HUMAN WASTE PRODUCT SAMPLES IN MICROBIOME RESEARCH TO DRIVE MARKET 133
TABLE 128 BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 129 NORTH AMERICA: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 130 EUROPE: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 131 ASIA PACIFIC: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 132 LATIN AMERICA: BIOBANKING MARKET FOR HUMAN WASTE PRODUCTS, BY COUNTRY, 2021–2028 (USD MILLION) 135
9 BIOBANKING MARKET, BY OWNERSHIP 136
9.1 INTRODUCTION 137
TABLE 133 BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 137
9.2 UNIVERSITIES 137
9.2.1 IMPORTANCE OF BIOBANKING IN ADVANCING RESEARCH TO DRIVE MARKET 137
TABLE 134 UNIVERSITY-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION) 138
TABLE 135 NORTH AMERICA: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 136 EUROPE: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 137 ASIA PACIFIC: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 138 LATIN AMERICA: UNIVERSITY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
9.3 NATIONAL/REGIONAL AGENCIES 140
9.3.1 SUSTAINED FUNDING AND STANDARDIZED PRACTICES TO SUPPORT MARKET GROWTH 140
TABLE 139 NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION) 141
TABLE 140 NORTH AMERICA: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 141 EUROPE: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 142 ASIA PACIFIC: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 143 LATIN AMERICA: NATIONAL/REGIONAL AGENCY-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 142
9.4 NON-PROFIT ORGANIZATIONS 142
9.4.1 FOCUS OF NON-PROFIT ORGANIZATIONS ON ADVANCING RESEARCH TO DRIVE MARKET 142
TABLE 144 NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION) 143
TABLE 145 NORTH AMERICA: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 146 EUROPE: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 147 ASIA PACIFIC: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 148 LATIN AMERICA: NON-PROFIT ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 145
9.5 PRIVATE ORGANIZATIONS 145
9.5.1 INCREASING OWNERSHIP OF BIOBANKS BY PRIVATE ORGANIZATIONS TO DRIVE MARKET 145
TABLE 149 PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION) 146
TABLE 150 NORTH AMERICA: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 151 EUROPE: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 152 ASIA PACIFIC: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 153 LATIN AMERICA: PRIVATE ORGANIZATION-OWNED BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
10 BIOBANKING MARKET, BY APPLICATION 148
10.1 INTRODUCTION 149
TABLE 154 BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 149
10.2 REGENERATIVE MEDICINE 149
10.2.1 INCREASING RESEARCH AND RISING GOVERNMENT FUNDING TO DRIVE MARKET 149
TABLE 155 BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2021–2028 (USD MILLION) 150
TABLE 156 NORTH AMERICA: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 157 EUROPE: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 158 ASIA PACIFIC: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 159 LATIN AMERICA: BIOBANKING MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION) 151
10.3 LIFE SCIENCE RESEARCH 152
10.3.1 INCREASING DEMAND AND UTILIZATION OF BIOBANKS IN LIFE SCIENCE RESEARCH APPLICATIONS TO SUPPORT MARKET GROWTH 152
FIGURE 29 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026 152
TABLE 160 BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY REGION, 2021–2028 (USD MILLION) 153
TABLE 161 NORTH AMERICA: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 153
TABLE 162 EUROPE: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 163 ASIA PACIFIC: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 164 LATIN AMERICA: BIOBANKING MARKET FOR LIFE SCIENCE RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 154
10.4 CLINICAL RESEARCH 155
10.4.1 GROWING FOCUS ON BIOMARKER DISCOVERY AND ACCELERATED DRUG DEVELOPMENT TO PROPEL MARKET 155
TABLE 165 BIOBANKING MARKET FOR CLINICAL RESEARCH, BY REGION, 2021–2028 (USD MILLION) 156
TABLE 166 NORTH AMERICA: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 167 EUROPE: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 156
TABLE 168 ASIA PACIFIC: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 169 LATIN AMERICA: BIOBANKING MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 157
11 BIOBANKING MARKET, BY END USER 158
11.1 INTRODUCTION 159
TABLE 170 BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 159
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS 159
11.2.1 LARGEST END USER SEGMENT DUE TO GROWING NUMBER OF CLINICAL TRIALS AND RESEARCH STUDIES 159
TABLE 171 BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY REGION, 2021–2028 (USD MILLION) 160
TABLE 172 NORTH AMERICA: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 173 EUROPE: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 174 ASIA PACIFIC: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 175 LATIN AMERICA: BIOBANKING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND CROS, BY COUNTRY, 2021–2028 (USD MILLION) 162
11.3 ACADEMIC AND RESEARCH INSTITUTES 162
11.3.1 ADVANCEMENTS IN SCIENTIFIC RESEARCH AND INNOVATION TO DRIVE MARKET 162
TABLE 176 BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 163
TABLE 177 NORTH AMERICA: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 178 EUROPE: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 179 ASIA PACIFIC: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 180 LATIN AMERICA: BIOBANKING MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 164
11.4 HOSPITALS 165
11.4.1 USE BIOBANKING TO COLLECT, STORE, AND MANAGE PATIENT SAMPLES FOR DIAGNOSTIC PURPOSES 165
TABLE 181 BIOBANKING MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION) 165
TABLE 182 NORTH AMERICA: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 183 EUROPE: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 184 ASIA PACIFIC: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 185 LATIN AMERICA: BIOBANKING MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 167
12 BIOBANKING MARKET, BY REGION 168
12.1 INTRODUCTION 169
TABLE 186 BIOBANKING MARKET, BY REGION, 2021–2028 (USD MILLION) 169
12.2 NORTH AMERICA 169
12.2.1 RECESSION IMPACT 170
FIGURE 30 NORTH AMERICA: BIOBANKING MARKET SNAPSHOT 170
TABLE 187 NORTH AMERICA: BIOBANKING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 188 NORTH AMERICA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 171
TABLE 189 NORTH AMERICA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 190 NORTH AMERICA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 191 NORTH AMERICA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 192 NORTH AMERICA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 172
TABLE 193 NORTH AMERICA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 173
TABLE 194 NORTH AMERICA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 173
TABLE 195 NORTH AMERICA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 174
TABLE 196 NORTH AMERICA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 174
12.2.2 US 174
12.2.2.1 Largest market in North America due to surge in genomic research 174
TABLE 197 US: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 175
TABLE 198 US: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 199 US: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 200 US: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 201 US: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 177
TABLE 202 US: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 177
TABLE 203 US: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 177
TABLE 204 US: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 178
TABLE 205 US: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 178
12.2.3 CANADA 178
12.2.3.1 Increasing number of biobanks to support market 178
TABLE 206 CANADA: BIOBANKING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 179
TABLE 207 CANADA: BIOBANKING EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 208 CANADA: BIOBANKING CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 209 CANADA: BIOBANKING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 210 CANADA: BIOBANKING MARKET, BY STORAGE TYPE, 2021–2028 (USD MILLION) 180
TABLE 211 CANADA: BIOBANKING MARKET, BY SAMPLE TYPE, 2021–2028 (USD MILLION) 181
TABLE 212 CANADA: BIOBANKING MARKET, BY OWNERSHIP, 2021–2028 (USD MILLION) 181
TABLE 213 CANADA: BIOBANKING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 181
TABLE 214 CANADA: BIOBANKING MARKET, BY END USER, 2021–2028 (USD MILLION) 182

ページTOPに戻る

Table of Contents

Summary

The global biobanking market is projected to reach USD 5.0 billion by 2028 from USD 2.9 billion in 2023, at a CAGR of 11.4% during the forecast period of 2023 to 2028. The growth of this market is majorly driven by the demand for cord blood stem cell preservation. The increasing trend of preserving cord blood stem cells from newborns has led to a significant increase in the number of cord blood banks and biobanks that specialize in the preservation of cord blood stem cells. These biobanks store cord blood samples for long-term use and provide services, and are a valuable resource for researchers and clinicians studying regenerative medicine.

“The consumables segment accounted for the second-largest share by product during the forecast period”
In 2022, consumables segment accounted for the second-largest share by product in the global biobanking market. Biobanking consumables primarily include reagents and media, nucleic acid extraction kits, surface disinfectants, collection kits, swabs, containers, and syringes. Consumables are indispensable and integral components of biobanking. With the rising demand for the biobanking of cells, tissues, and organs, the requirement for biobanking equipment and consumables has increased significantly. Furthermore, there is a growing demand for storage equipment in the biobanking industry, with an increasing number of samples being stored for research and clinical applications. These trends underscore the importance of reliable and effective storage consumables in maintaining the integrity and accessibility of valuable biological specimens

“Europe: The second largest region in the biobanking market”
Europe is the second-largest market for biobanking after North America. The European biobanking market has witnessed significant growth in recent years, driven by various factors that have propelled its expansion. One notable factor is the increasing focus on personalized medicine and precision healthcare, which has created a burgeoning demand for high-quality biological samples and associated data. Furthermore, the advancements in genomic research and the advent of next-generation sequencing technologies have stimulated the need for vast repositories of biological materials, fueling the growth of biobanking activities across Europe. This upward trajectory in the European biobanking market exemplifies its vital role in facilitating biomedical research, enabling the development of innovative diagnostics, therapies, and treatments for improved patient outcomes

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80% and Demand Side 20%
• By Designation: C-level - 45%, D-level - 30%, and Others - 25%
• By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%
List of Companies Profiled in the Report:
• Thermo Fisher Scientific, Inc. (US)
• PHC Holdings Corporation (Japan)
• Becton, Dickinson and Company (US)
• QIAGEN N.V. (Germany)
• Merck KGaA (Germany)
• Avantor, Inc. (US)
• Cryoport, Inc. (US)
• Tecan Trading AG (Switzerland)
• Azenta, Inc. (US)
• Greiner Holding AG (Austria)
• Hamilton Company (US)
• Micronic (Netherlands)
• AMSBIO (UK)
• Bay Biosciences LLC (US)
• BioKryo (Germany)
• SPT Labtech (UK)
• ASKION GmbH (Germany)
• Cell&Co BioServices (France)
• Ziath Ltd. (UK)
• CTIBiotech (France)
• Cureline (US)
• Firalis Group (France)
• Sopachem (Netherlands)
• ProteoGenex (US)
• US Biolab Corporation, Inc. (US)

Research Coverage:
This report provides a detailed picture of the biobanking market. It aims at estimating the size and future growth potential of the market across different segments such as the product & service, sample type, storage type, ownership, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
The report provides insights on the following pointers:
• Analysis of key drivers (growing investments and funding for biobanks, focus on genetic testing and precision medicine, increasing trend in preservation of cord blood stem cells from newborns, favorable funding scenario for research related to regenerative medicine), restraints (High cost of automated equipment, issues related to biospecimen sample management), opportunities (emerging countries to provide lucrative opportunities), and challenges (high operational cost of biobanks, storage of samples) influencing the growth of the market.
• Product and Service Development/Innovation: Detailed insights on newly launched products & services, and technological assessment of the biobanking market
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the biobanking market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and products and service offerings of leading players like Thermo Fisher Scientific, Inc. (US), PHC Holdings Corporation (Japan), Becton, Dickinson and Company (US), QIAGEN N.V. (Germany), Merck KGaA (Germany), Avantor, Inc. (US), Cryoport, Inc. (US), Tecan Trading AG (Switzerland), Azenta, Inc. (US), Greiner Holding AG (Austria), Hamilton Company (US), Micronic (Netherlands), AMSBIO (UK), Bay Biosciences LLC (US), BioKryo (Germany), SPT Labtech (UK), ASKION GmbH (Germany), Cell&Co BioServices (France), Ziath Ltd. (UK), CTIBiotech (France), Cureline (US), Firalis Group (France), Sopachem (Netherlands), ProteoGenex (US), and US Biolab Corporation, Inc. (US) and among others in the market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（clinical research）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（clinical research）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?